SELARL SARAMITO - PHARMACIE DE LA COUPOLE : revenue, balance sheet and financial ratios

SELARL SARAMITO - PHARMACIE DE LA COUPOLE is a French company founded 17 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in NIMES (30000), this company of category PME shows in 2020 a revenue of 879 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL SARAMITO - PHARMACIE DE LA COUPOLE (SIREN 508159803)
Indicator 2024 2020 2019 2018 2017 2016
Revenue N/C 878 853 € 865 776 € 945 946 € 857 668 € 976 709 €
Net income 24 274 € 18 423 € 19 602 € 40 873 € 21 965 € 18 080 €
EBITDA N/C 42 259 € 42 371 € 74 692 € 54 992 € 67 420 €
Net margin N/C 2.1% 2.3% 4.3% 2.6% 1.9%

Revenue and income statement

En 2024, SELARL SARAMITO - PHARMACIE DE LA COUPOLE genera un resultado neto positivo de 24 k€. Evolución 2016-2024: 18 k€ -> 24 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

24 274 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 44%. La deuda permanece bajo control. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 38%. El equilibrio entre fondos propios y deuda es satisfactorio.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

44.127%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

37.672%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

31.9%

Solvency indicators evolution
SELARL SARAMITO - PHARMACIE DE LA COUPOLE

Sector positioning

Ratio de endeudamiento
44.13 2024
2019
2020
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Bueno +13 pts over 3 years

En 2024, el ratio de endeudamiento de SELARL SARAMITO - PHARMAC... (44.13) se sitúa por debajo de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Esta posición controlada refleja una gestión prudente.

Autonomía financiera
37.67% 2024
2019
2020
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +9 pts over 3 years

En 2024, el autonomía financiera de SELARL SARAMITO - PHARMAC... (37.7%) se sitúa por debajo de la mediana del sector. Este ratio representa la parte del patrimonio en la financiación total. Una mejora fortalecería la posición competitiva.

Capacidad de reembolso
3.82 ans 2020
2019
2020
Q1: 1.45 ans
Med: 4.71 ans
Q3: 9.3 ans
Bueno

En 2020, el capacidad de reembolso de SELARL SARAMITO - PHARMAC... (3.8 ans) se sitúa por debajo de la mediana del sector. Este ratio indica el número de años necesarios para pagar la deuda con flujo de caja. Esta posición controlada refleja una gestión prudente.

Liquidity ratios

El ratio de liquidez se sitúa en 26.57. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

26.574

Liquidity indicators evolution
SELARL SARAMITO - PHARMACIE DE LA COUPOLE

Sector positioning

Ratio de liquidez
26.57 2024
2019
2020
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Vigilar

En 2024, el ratio de liquidez de SELARL SARAMITO - PHARMAC... (26.57) se sitúa en el 25% más bajo del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Un ratio inferior a 1 puede señalar tensiones potenciales de flujo de caja.

Cobertura de intereses
0.02x 2020
2019
2020
Q1: 0.68x
Med: 3.87x
Q3: 8.37x
Average

En 2020, el cobertura de intereses de SELARL SARAMITO - PHARMAC... (0.0x) se sitúa por debajo de la mediana del sector. Este ratio indica cuántas veces el resultado operativo cubre los gastos de intereses. Una mejora fortalecería la posición competitiva.

Working capital requirement (WCR) and payment terms

El fondo de maniobra operativo (FM) mide el desfase temporal de tesorería.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL SARAMITO - PHARMACIE DE LA COUPOLE

Positioning of SELARL SARAMITO - PHARMACIE DE LA COUPOLE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL SARAMITO - PHARMACIE DE LA COUPOLE is estimated at 338 882 € (range 235 992€ - 506 988€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
235k€ 338k€ 506k€
338 882 € Range: 235 992€ - 506 988€
NAF 5 année 2024

Valuation method used

Net Income Multiple
24 274 € × 14.0x = 338 883 €
Range: 235 993€ - 506 988€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL SARAMITO - PHARMACIE DE LA COUPOLE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL SARAMITO - PHARMACIE DE LA COUPOLE

What is the revenue of SELARL SARAMITO - PHARMACIE DE LA COUPOLE ?

The revenue of SELARL SARAMITO - PHARMACIE DE LA COUPOLE in 2020 is 879 k€.

Is SELARL SARAMITO - PHARMACIE DE LA COUPOLE profitable?

Yes, SELARL SARAMITO - PHARMACIE DE LA COUPOLE generated a net profit of 24 k€ in 2024.

Where is the headquarters of SELARL SARAMITO - PHARMACIE DE LA COUPOLE ?

The headquarters of SELARL SARAMITO - PHARMACIE DE LA COUPOLE is located in NIMES (30000), in the department Gard.

Where to find the tax return of SELARL SARAMITO - PHARMACIE DE LA COUPOLE ?

The tax return of SELARL SARAMITO - PHARMACIE DE LA COUPOLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL SARAMITO - PHARMACIE DE LA COUPOLE operate?

SELARL SARAMITO - PHARMACIE DE LA COUPOLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.